U.S. Markets closed

STADA Arzneimittel Aktiengesellschaft (SAZ.DE)


XETRA - XETRA Delayed Price. Currency in EUR
Add to watchlist
65.92-0.43 (-0.65%)
At close: 5:35PM CEST
Interactive chart
Previous Close66.35
Open66.15
Bid0.00 x 5000
Ask0.00 x 28500
Day's Range65.80 - 66.19
52 Week Range40.35 - 66.50
Volume363,267
Avg. Volume497,761
Market Cap4.1B
BetaN/A
PE Ratio (TTM)38.91
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Thomson Reuters StreetEvents5 days ago

    Edited Transcript of SAZ.DE earnings conference call or presentation 11-May-17 11:00am GMT

    Q1 2017 STADA Arzneimittel AG Earnings Call

  • Reuters7 days ago

    Advent, Shanghai Pharma have not approached Stada -sources

    FRANKFURT/LONDON, May 15 (Reuters) - German drug company Stada Arzneimittel AG has not been approached by Advent International or Shanghai Pharmaceuticals Holding with a counter offer, two sources close to the matter told Reuters on Monday. Rival buyout firms Bain and Cinven had offered to buy Stada in April, which seemed to end the contest to acquire the generic drug maker, but Bloomberg reported on Monday that Advent and Shanghai Pharmaceuticals are considering making an offer. Bain and Cinven's offer of 65.28 euros per share and a dividend of 0.72 euros per Stada share was a surprisingly large increase on a previous bid and valued the company at about 5.3 billion euros ($5.81 billion).

  • Reuters7 days ago

    Advent and Shanghai Pharma consider rival bid for Stada -Bloomberg

    Buyout firm Advent International Corp and Shanghai Pharmaceuticals Holding Co are considering making an offer for German drug company Stada Arzneimittel AG , Bloomberg reported on Monday. Advent and Shanghai Pharmaceuticals are discussing a potential bid of about 70 euros a share, Bloomberg reported, citing people familiar with the matter. Rival buyout groups Bain Capital and Cinven have been vying with a consortium comprising Advent and Permira for control of Stada.